These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3441615)

  • 1. Whole body scintigram with 131I before and immediately after the ablation or tumor dose in patients with differentiated thyroid carcinoma and the effect of endogenous stimulation of thyrostimulating hormone on thyroglobulin in same patients.
    Malesevic M; Stefanovic L; Popovic S; Prvulovic M; Selir Z; Milkovic L
    Radiobiol Radiother (Berl); 1987; 28(5):651-3. PubMed ID: 3441615
    [No Abstract]   [Full Text] [Related]  

  • 2. Moderate hypothyroidism in preparation for whole body 131I scintiscans and thyroglobulin testing.
    Greenspan FS
    Thyroid; 1996 Oct; 6(5):493. PubMed ID: 8936677
    [No Abstract]   [Full Text] [Related]  

  • 3. The value of diagnostic whole-body scanning and serum thyroglobulin in the presence of elevated serum thyrotropin during follow-up of anti-thyroglobulin antibody-positive patients with differentiated thyroid carcinoma who appeared to be free of disease after total thyroidectomy and radioactive iodine ablation.
    Rosario PW; Mineiro Filho AF; Lacerda RX; dos Santos DA; Calsolari MR
    Thyroid; 2012 Feb; 22(2):113-6. PubMed ID: 22224815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of scan-negative, thyroglobulin-positive metastatic thyroid cancer using radioiodine 131I and recombinant human thyroid stimulating hormone.
    Rudavsky AZ; Freeman LM
    J Clin Endocrinol Metab; 1997 Jan; 82(1):11-4. PubMed ID: 8989223
    [No Abstract]   [Full Text] [Related]  

  • 5. Thyroglobulin and 131I uptake of remaining tissue in patients with differentiated carcinoma after thyroidectomy.
    Moser E; Fritsch S; Braun S
    Nucl Med Commun; 1988 Apr; 9(4):262-6. PubMed ID: 3399222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum thyroglobulin and iodine-131 whole-body scan in the diagnosis and assessment of treatment for metastatic differentiated thyroid carcinoma.
    Lubin E; Mechlis-Frish S; Zatz S; Shimoni A; Segal K; Avraham A; Levy R; Feinmesser R
    J Nucl Med; 1994 Feb; 35(2):257-62. PubMed ID: 8294995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ruling out 131I ablation in low-risk differentiated thyroid carcinoma basing on thyroglobulin measurement.
    Giovanella L; Verburg FA
    Thyroid; 2011 Jul; 21(7):809-10; author reply 811-2. PubMed ID: 21615306
    [No Abstract]   [Full Text] [Related]  

  • 8. Sequential serum thyroglobulin determinations, 131I scans, and 131I uptakes after triiodothyronine withdrawal in patients with thyroid cancer.
    Schneider AB; Line BR; Goldman JM; Robbins J
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1199-206. PubMed ID: 7298799
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of postoperative 131I treatment on thyroglobulin measurements in the follow-up of patients with thyroid cancer.
    Baskin HJ
    Thyroid; 1994; 4(3):239-42. PubMed ID: 7833657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rational basis for the therapy of differentiated carcinoma of the thyroid].
    Nosari I; Tidone L; Ferrari L; Montini M; Sileo F; Pagani G; Gelli D
    Recenti Prog Med; 1984; 75(7-8):758-74. PubMed ID: 6438737
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical value of serum thyroglobulin and 131I-whole body retention measurements in the diagnosis of metastases from differentiated thyroid carcinoma (author's transl)].
    Weissel M; Bergmann H; Höfer R
    Acta Med Austriaca; 1980; 7(4-5):114-9. PubMed ID: 7246011
    [No Abstract]   [Full Text] [Related]  

  • 12. Complementary role of whole body scan and serum thyroglobulin determination in the follow-up of differentiated thyroid carcinoma.
    Ronga G; Fiorentino A; Fragasso G; Fringuelli FM; Todino V
    Ital J Surg Sci; 1986; 16(1):11-5. PubMed ID: 3087907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroglobulin radioimmunoassay and 131I scintigraphy in patients with differentiated thyroid carcinoma.
    Lindegaard MW; Paus E; Høie J; Kullman G; Stenwig AE
    Acta Chir Scand; 1988 Feb; 154(2):141-5. PubMed ID: 3354295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early sequential changes in serum thyroglobulin after radioiodine ablation for thyroid cancer: possible clinical implications for recombinant human thyrotropin-aided therapy.
    Taïeb D; Lussato D; Guedj E; Roux F; Mundler O
    Thyroid; 2006 Feb; 16(2):177-9. PubMed ID: 16676403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [131I-accumulating pulmonary and bone metastases of differentiated thyroid cancer with low serum thyroglobulin levels--an exception in tumor follow-up?].
    Arning G; Ehrenheim C; Schober O; Hundeshagen H
    Nuklearmedizin; 1987 Jun; 26(3):139-42. PubMed ID: 3628022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of thyroglobulin positive/whole-body scan negative: is Tg positive/131I therapy useful?
    McDougall IR
    J Endocrinol Invest; 2001 Mar; 24(3):194-8. PubMed ID: 11314751
    [No Abstract]   [Full Text] [Related]  

  • 17. Stimulated thyroglobulin and neck ultrasonography facilitates postsurgical radioactive iodine remnant ablation selection in patients with low-risk well-differentiated thyroid carcinoma.
    Gomez Hernandez K; Etarsky D; Orlov S; Walfish PG
    Thyroid; 2012 Jul; 22(7):760-1. PubMed ID: 22663549
    [No Abstract]   [Full Text] [Related]  

  • 18. [Follow-up of patients with differentiated thyroid cancer: determination of serum thyroglobulin in place of routine 131I scintigraphy?].
    Schatz H; Grebe SF; Horn W; Müller H
    Wien Klin Wochenschr; 1984 May; 96(10):389-93. PubMed ID: 6475061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum thyroglobulin in the diagnosis of metastases of differentiated thyroid cancer. Effect of suppressive thyroid hormone substitution on the diagnostic accuracy of thyroglobulin values].
    Müller-Gärtner HW; Schneider C; Tempel MT
    Nuklearmedizin; 1986 Oct; 25(5):194-200. PubMed ID: 3797259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thallium-201 scintigraphy in differentiated thyroid cancer: comparison with radioiodine scintigraphy and serum thyroglobulin determinations.
    Ramanna L; Waxman A; Braunstein G
    J Nucl Med; 1991 Mar; 32(3):441-6. PubMed ID: 2005453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.